Skip to main content
Correlative results from NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma. Bose, S., Ingham, M., Chen, L., Kochupurakkal, B., Marino-Enriquez, A., Allred, J. B., George, S., Attia, S., Burgess, M., Seetharam, M., Boikos, S., Bui, N., Chen, J., Close, J., Cote, G., Ivy, S., Das, B., Shapiro, G., Schwartz, G. K. LIPPINCOTT WILLIAMS & WILKINS. 2022

View details for Web of Science ID 000863680300351